Combination chemotherapy together with interferon-alpha (IFN-alpha) in metastatic melanoma (MM), a multicenter phase II study

The use of interferon alfa in the treatment of metastatic cutaneous melanoma

Shepherd, J.
Milne, R.
Wessex Inst. for Health Research and Development, Southampton (United Kingdom). Development and Evaluation Committee

January 1999

SIGLEAvailable from British Library Document Supply Centre-DSC:3578.772(99) / BLDSC - British Librar...

Use of interferon alpha in patients with metastatic malignant melanoma: A retrospective analysis Metastati̇k mali̇gn melanom hastalarinda kemoi̇mmunoterapi̇ sonuçlari: Retrospekti̇f bi̇r anali̇z

Eser, Bülent
Özlem, E.R.
Coşkun, H. Şenol
Şivgin, Serdar
Çetin, MUSTAFA
Ünal, Ali
Altinbaş, Mustafa

January 2002

Purpose: Malign melanoma has a rapid and atypical clinical course which responds to chemoimmunothera...

The Anticancer Face of Interferon Alpha (IFN-Alpha): From Biology to Clinical Results, with a Focus on Melanoma

Pasquali, Sandro
Mocellin, Simone

January 2010

Alpha interferons (IFN) are type I IFNs that have pleiotropic effects on cell functions. A wealth of...

Chemoimmunotherapy with bleomycin, vincristine, lomustine, dacarbazine (BOLD) plus interferon alpha for metastatic melanoma: a multicentre phase II study

Punt, C.J.A.
Herpen, C.M.L. van
Jansen, R.L.H.
Vreugdenhil, A.
Muller, E.W.
Mulder, P.H.M. de

January 1997

Contains fulltext : 25471.PDF (publisher's version ) (Open Access

Interferon alfa-2a and interleukin-2 with or without cisplatin in metastatic melanoma: a randomized trial of the European Organization for Research and Treatment of Cancer Melanoma Cooperative Group

Keilholz, U.
Goey, S.H.
Punt, C.J.A.
Proebstle, T.M.
Salzmann, R.
Scheibenbogen, C.
Schadendorf, D.
Liénard, D.
Enk, A.
Dummer, R.
Hantich, B.
Geueke, A.-M.
Eggermont, A.M.M.

January 1997

Contains fulltext : 26097___.PDF (publisher's version ) (Open Access

Fotemustine and tamoxifen combination therapy in metastatic malignant melanoma. A phase II study

Punt, C.J.A.
Tytgat, J.H.
Liessum, P.A. van
Gerard, B.

January 1995

Contains fulltext : 22064___.PDF (publisher's version ) (Open Access

Dose efficacy study of two schedules of high-dose bolus administration of interleukin-2 and interferon alpha in metastatic melanoma

Kruit, W.H.J.
Punt, C.J.A.
Goey, S.H.
Mulder, P.H.M. de
Gratama, J.W.
Eggermont, A.M.M.
Bolhuis, R.L.H.
Stoter, G.J.

January 1996

Contains fulltext : 23736.PDF (publisher's version ) (Open Access

Dacarbazine, cisplatin, and interferon-alfa-2b with or without interleukin-2 in metastatic melanoma: a randomized phase III trial (18951) of the European Organisation for Research and Treatment of Cancer Melanoma Group.

Keilholz, U.
Punt, C.J.A.
Gore, M.
Kruit, W.
Patel, P.
Lienard, D.
Thomas, J.
Proebstle, T.M.
Schmittel, A.
Schadendorf, D.
Velu, T.
Negrier, S.
Kleeberg, U.R.
Lehman, F.
Suciu, S.
Eggermont, A.M.M.

January 2005

Contains fulltext : 49220schadendorf.pdf (publisher's version ) (Closed access)BAC...

A Phase II Trial of Recombinant Interferon Alpha-2b and Cisplatin in Metastatic Melanoma

Lars Bastholt
Janne Bække
Carsten Rytter
Henning Mouridsen
Ebbe Lindegård Madsen
Kirsten Møholt
Lars Bastholt

January 2000

A phase II trial of recombinant interferon alpha-2b and cisplatin in metastatic melanom

Phase II study of E7070 in patients with metastatic melanoma.

Smyth, J.F.
Aamdal, S.
Awada, A.
Dittrich, C.
Caponigro, F.
Schoffski, P.
Gore, M.
Lesimple, T.
Djurasinovic, N.
Baron, B.
Ravic, M.
Fumoleau, P.
Punt, C.J.A.

January 2005

Contains fulltext : 49133ravic.pdf (publisher's version ) (Closed access)E7070 is ...

Phase II Trial of Cisplatin and a-Interferon in Advanced Malignant Melanoma

A. Margolin
James H. Doroshow
Steven A. Akman
Lucille A. Leong
Robert J. Morgan
George Somlo
James Raschko
Cynthia Pereira
Lisa Yonemoto
Chul Ahn

January 1992

Purpose: To evaluate the antitumor activity of combi-nation cisplatin (CDDP) and a-interferon (a-IFN...

Interferon alfa-2a and interleukin-2 with or without cisplatin in metastatic melanoma: a randomized trial of the European Organization for Research and Treatment of Cancer Melanoma Cooperative Group.

Keilholz, U.
Goey, S.H.
Punt, C.J.
Proebstle, T.M.
Salzmann, R.
Scheibenbogen, C.
Schadendorf, D.
Liénard, D.
Enk, A.
Dummer, R.
Hantich, B.
Geueke, A.M.
Eggermont, A.M.

January 1997

PURPOSE: The combination of interferon alfa-2a (IFN alpha) and high-dose interleukin-2 (IL-2) is act...

Metastatic malignant melanoma: Combination of interferon alpha 2b and dacarbazine

Ulus A. Şanlı
Banu Ç. Bilkay

January 1999

Tek ajan olarak dacarbazine (DTIC) metastatik malign melanomlu (MMM) hastalarda standart tedavidir. ...

A phase I trial of recombinant interferon-alpha and alpha-difluoromethylornithine in metastatic melanoma.

Croghan, MK
Booth, A
Meyskens, FL

August 1988

Both interferon-alpha (IFN-alpha) and alpha-difluoromethylornithine (DFMO) have shown modest activit...

Disseminated Malignant Melanoma and Recombinant Interferon: Analysis of Seven Consecutive Phase II Investigations

Creagan, Edward T.
Schaid, Daniel J.
Ahmann, David L.
Frytak, Stephen

December 1990

We have performed seven phase II trials with recombinant interferons (IFN) involving 191 patients wi...

The use of interferon alfa in the treatment of metastatic cutaneous melanoma

Shepherd, J.
Milne, R.
Wessex Inst. for Health Research and Development, Southampton (United Kingdom). Development and Evaluation Committee

January 1999

SIGLEAvailable from British Library Document Supply Centre-DSC:3578.772(99) / BLDSC - British Librar...

Use of interferon alpha in patients with metastatic malignant melanoma: A retrospective analysis Metastati̇k mali̇gn melanom hastalarinda kemoi̇mmunoterapi̇ sonuçlari: Retrospekti̇f bi̇r anali̇z

Eser, Bülent
Özlem, E.R.
Coşkun, H. Şenol
Şivgin, Serdar
Çetin, MUSTAFA
Ünal, Ali
Altinbaş, Mustafa

January 2002

Purpose: Malign melanoma has a rapid and atypical clinical course which responds to chemoimmunothera...

The Anticancer Face of Interferon Alpha (IFN-Alpha): From Biology to Clinical Results, with a Focus on Melanoma

Pasquali, Sandro
Mocellin, Simone

January 2010

Alpha interferons (IFN) are type I IFNs that have pleiotropic effects on cell functions. A wealth of...

Chemoimmunotherapy with bleomycin, vincristine, lomustine, dacarbazine (BOLD) plus interferon alpha for metastatic melanoma: a multicentre phase II study

Punt, C.J.A.
Herpen, C.M.L. van
Jansen, R.L.H.
Vreugdenhil, A.
Muller, E.W.
Mulder, P.H.M. de

January 1997

Contains fulltext : 25471.PDF (publisher's version ) (Open Access

Interferon alfa-2a and interleukin-2 with or without cisplatin in metastatic melanoma: a randomized trial of the European Organization for Research and Treatment of Cancer Melanoma Cooperative Group

Keilholz, U.
Goey, S.H.
Punt, C.J.A.
Proebstle, T.M.
Salzmann, R.
Scheibenbogen, C.
Schadendorf, D.
Liénard, D.
Enk, A.
Dummer, R.
Hantich, B.
Geueke, A.-M.
Eggermont, A.M.M.

January 1997

Contains fulltext : 26097___.PDF (publisher's version ) (Open Access

Fotemustine and tamoxifen combination therapy in metastatic malignant melanoma. A phase II study

Punt, C.J.A.
Tytgat, J.H.
Liessum, P.A. van
Gerard, B.

January 1995

Contains fulltext : 22064___.PDF (publisher's version ) (Open Access

Dose efficacy study of two schedules of high-dose bolus administration of interleukin-2 and interferon alpha in metastatic melanoma

Kruit, W.H.J.
Punt, C.J.A.
Goey, S.H.
Mulder, P.H.M. de
Gratama, J.W.
Eggermont, A.M.M.
Bolhuis, R.L.H.
Stoter, G.J.

January 1996

Contains fulltext : 23736.PDF (publisher's version ) (Open Access

Dacarbazine, cisplatin, and interferon-alfa-2b with or without interleukin-2 in metastatic melanoma: a randomized phase III trial (18951) of the European Organisation for Research and Treatment of Cancer Melanoma Group.

Keilholz, U.
Punt, C.J.A.
Gore, M.
Kruit, W.
Patel, P.
Lienard, D.
Thomas, J.
Proebstle, T.M.
Schmittel, A.
Schadendorf, D.
Velu, T.
Negrier, S.
Kleeberg, U.R.
Lehman, F.
Suciu, S.
Eggermont, A.M.M.

January 2005

Contains fulltext : 49220schadendorf.pdf (publisher's version ) (Closed access)BAC...

A Phase II Trial of Recombinant Interferon Alpha-2b and Cisplatin in Metastatic Melanoma

Lars Bastholt
Janne Bække
Carsten Rytter
Henning Mouridsen
Ebbe Lindegård Madsen
Kirsten Møholt
Lars Bastholt

January 2000

A phase II trial of recombinant interferon alpha-2b and cisplatin in metastatic melanom

Phase II study of E7070 in patients with metastatic melanoma.

Smyth, J.F.
Aamdal, S.
Awada, A.
Dittrich, C.
Caponigro, F.
Schoffski, P.
Gore, M.
Lesimple, T.
Djurasinovic, N.
Baron, B.
Ravic, M.
Fumoleau, P.
Punt, C.J.A.

January 2005

Contains fulltext : 49133ravic.pdf (publisher's version ) (Closed access)E7070 is ...

Phase II Trial of Cisplatin and a-Interferon in Advanced Malignant Melanoma

A. Margolin
James H. Doroshow
Steven A. Akman
Lucille A. Leong
Robert J. Morgan
George Somlo
James Raschko
Cynthia Pereira
Lisa Yonemoto
Chul Ahn

January 1992

Purpose: To evaluate the antitumor activity of combi-nation cisplatin (CDDP) and a-interferon (a-IFN...

Interferon alfa-2a and interleukin-2 with or without cisplatin in metastatic melanoma: a randomized trial of the European Organization for Research and Treatment of Cancer Melanoma Cooperative Group.

Keilholz, U.
Goey, S.H.
Punt, C.J.
Proebstle, T.M.
Salzmann, R.
Scheibenbogen, C.
Schadendorf, D.
Liénard, D.
Enk, A.
Dummer, R.
Hantich, B.
Geueke, A.M.
Eggermont, A.M.

January 1997

PURPOSE: The combination of interferon alfa-2a (IFN alpha) and high-dose interleukin-2 (IL-2) is act...

Metastatic malignant melanoma: Combination of interferon alpha 2b and dacarbazine

Ulus A. Şanlı
Banu Ç. Bilkay

January 1999

Tek ajan olarak dacarbazine (DTIC) metastatik malign melanomlu (MMM) hastalarda standart tedavidir. ...

A phase I trial of recombinant interferon-alpha and alpha-difluoromethylornithine in metastatic melanoma.

Croghan, MK
Booth, A
Meyskens, FL

August 1988

Both interferon-alpha (IFN-alpha) and alpha-difluoromethylornithine (DFMO) have shown modest activit...

Disseminated Malignant Melanoma and Recombinant Interferon: Analysis of Seven Consecutive Phase II Investigations

Creagan, Edward T.
Schaid, Daniel J.
Ahmann, David L.
Frytak, Stephen

December 1990

We have performed seven phase II trials with recombinant interferons (IFN) involving 191 patients wi...

The use of interferon alfa in the treatment of metastatic cutaneous melanoma

Shepherd, J.
Milne, R.
Wessex Inst. for Health Research and Development, Southampton (United Kingdom). Development and Evaluation Committee

January 1999

SIGLEAvailable from British Library Document Supply Centre-DSC:3578.772(99) / BLDSC - British Librar...

Use of interferon alpha in patients with metastatic malignant melanoma: A retrospective analysis Metastati̇k mali̇gn melanom hastalarinda kemoi̇mmunoterapi̇ sonuçlari: Retrospekti̇f bi̇r anali̇z

Eser, Bülent
Özlem, E.R.
Coşkun, H. Şenol
Şivgin, Serdar
Çetin, MUSTAFA
Ünal, Ali
Altinbaş, Mustafa

January 2002

Purpose: Malign melanoma has a rapid and atypical clinical course which responds to chemoimmunothera...

The Anticancer Face of Interferon Alpha (IFN-Alpha): From Biology to Clinical Results, with a Focus on Melanoma

Pasquali, Sandro
Mocellin, Simone

January 2010

Alpha interferons (IFN) are type I IFNs that have pleiotropic effects on cell functions. A wealth of...

Combination chemotherapy together with interferon-alpha (IFN-alpha) in metastatic melanoma (MM), a multicenter phase II study

Abstract

Extracted data

Combination chemotherapy together with interferon-alpha (IFN-alpha) in metastatic melanoma (MM), a multicenter phase II study

Abstract

Extracted data

Related items

Related items